Your browser doesn't support javascript.
loading
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Gross, Neil D; Miller, David M; Khushalani, Nikhil I; Divi, Vasu; Ruiz, Emily S; Lipson, Evan J; Meier, Friedegund; Su, Yungpo Bernard; Swiecicki, Paul L; Atlas, Jennifer; Geiger, Jessica L; Hauschild, Axel; Choe, Jennifer H; Hughes, Brett G M; Schadendorf, Dirk; Patel, Vishal A; Homsi, Jade; Taube, Janis M; Lim, Annette M; Ferrarotto, Renata; Yoo, Suk-Young; Mathias, Melissa; Han, Hyunsil; Seebach, Frank; Lowy, Israel; Fury, Matthew G; Rischin, Danny.
Affiliation
  • Gross ND; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Centre, Houston, TX, USA. Electronic address: ngross@mdanderson.org.
  • Miller DM; Department of Medicine, Division of Hematology/Oncology, and Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
  • Khushalani NI; Department of Cutaneous Oncology, Moffitt Cancer Centre, Tampa, FL, USA.
  • Divi V; Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA.
  • Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Lipson EJ; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins, Baltimore, MD, USA.
  • Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center, University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany.
  • Su YB; Head and Neck Medical Oncology, Nebraska Cancer Specialists, Omaha, NE, USA.
  • Swiecicki PL; Rogel Comprehensive Cancer Centre, University of Michigan, Ann Arbor, MI, USA.
  • Atlas J; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Geiger JL; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hauschild A; Department of Dermatology, Schleswig-Holstein University Hospital, Kiel, Germany.
  • Choe JH; Duke Cancer Institute, Durham, NC, USA.
  • Hughes BGM; Department of Cancer Care Services, Royal Brisbane and Women's Hospital and University of Queensland, Brisbane, QLD, Australia.
  • Schadendorf D; Department of Dermatology, University Hospital of Essen and German Cancer Consortium, Partner Site Essen, Essen, Germany.
  • Patel VA; Departments of Dermatology, Medicine, and Oncology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
  • Homsi J; Harold C Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Taube JM; Department of Dermatology, Johns Hopkins Hospital, Baltimore, MD, USA.
  • Lim AM; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.
  • Ferrarotto R; Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Centre, Houston, TX, USA.
  • Yoo SY; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Mathias M; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Han H; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Seebach F; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Lowy I; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Fury MG; Regeneron Pharmaceuticals, Tarrytown, NY, USA.
  • Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.
Lancet Oncol ; 24(11): 1196-1205, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37875144

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell Limits: Aged / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Squamous Cell Limits: Aged / Female / Humans / Male Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2023 Type: Article